HomeOpen Access NewsResearch & Innovation

Research & Innovation

Investing in Britain’s satellite intelligence

Forbes McKenzie, CEO of McKenzie Intelligence Services, explores investments in Britain’s satellite intelligence, strategically focusing on our core strengths.

MASTERPLANS to disentangle Systemic Lupus Erythematosus (SLE)

Professor Ian N Bruce MD FRCP, Professor of Rheumatology at the University of Manchester shares his expertise here on Systemic Lupus Erythematosus (SLE), a chronic multisystem autoimmune condition.

Developing convenient consumer products from pelagic fish in Europe

Turid Rustad, Professor at NTNU explains the development of convenient consumer products from pelagic fish, including the recent growth of European fish consumption.

Physics: Negative ion formation in complex heavy systems

Dr Alfred Msezane from Clark Atlanta University’s Department of Physics lavishes us with his knowledge about an intriguing aspect of physics, which focusses on his research on negative ion formation in complex heavy systems.

Advancing basic chemical research while developing a globally competitive workforce

Carol Bessel and Melissa Olson from National Science Foundation’s Division of Chemistry (CHE) reveal the organisation’s goal of advancing basic chemical research while also developing a globally competitive workforce.

Health research and genomic data in Finland

In this question and answer interview, Liisa Maria Voipio-Pulkki, at the Finnish Ministry of Social Affairs and Health, shares her thoughts on health research and genomic data in Finland.

Chemistry and biochemistry: Sugar conformational equilibria and dynamics

Ian Carmichaela, Robert J. Woodsb and Anthony S. Seriannic share their expertise on an aspect of chemistry and biochemistry that concerns circular statistics and NMR which reveal sugar conformational equilibria and dynamics.

Clinical Contract Research: Building the digital bridge between clinical research and clinical care

Prof Dr Freimut Schliess, Director, Science & Innovation at Profil GmbH, sheds light on how Clinical Contract Research Organisations are building the digital bridge connecting clinical research and clinical care.

What is Polar Research and Expedition Consultancy?

Here, Wilson Cheung Wai Yin from the Polar Research & Expedition Consultancy (PRECON) tells us why this organisation was set up – to encourage the cost-effectiveness of scientific field research in the Polar Regions.

Understanding chronic autoimmune uveitis through ophthalmology research

Andrew Taylor, Professor of Ophthalmology, highlights research to understand the molecules that mediate ocular immune privilege so they can be adapted for chronic autoimmune uveitis.

Microfluidic devices: The future is here

Dr Stefan H. Bossmann and Dr Christopher T. Culbertson, Professors of Chemistry at Kansas State University, explain why microfluidic devices are in their view, the future.

Ophthalmology: A focus on uveitis – the inflammation of the uveal tract

Dr Gerry Morrow explains what you need to know about an aspect of ophthalmology called uveitis, defined as inflammation of the uveal tract, which comprises the iris, ciliary body and choroid.

Making chemistry matter: The value of discovery

Prof Colin J Suckling OBE DSc FRSE from the Department of Pure & Applied Chemistry, at University of Strathclyde, explains the value of discovery when it comes to making chemistry matter.

Diversity and interculturalism in cities worldwide

Diversity and interculturalism in cities worldwide are placed under the spotlight here by Dr Gideon Bolt, from the Department of Human Geography and Planning Faculty of Geosciences at Utrecht University in the Netherlands.

Chemistry for the future of Europe

Alex Schiphorst, Science Communication and Policy Officer discusses the vital role of chemistry when it comes to the future of Europe.

A focus on battery development in Europe

Here, Bo Normark, Thematic Leader Smartgrids & Storage, EIT InnoEnergy explains precisely why the EBA is the catalyst for battery development in Europe.

Cutting-edge life sciences and technologies: Assessing chemicals exposure toxicity

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group explains cutting-edge life sciences and technologies that assess exposure toxicity when it comes to chemicals, including novel tools to address human health and environment.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders